Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach
2021 · Scientific Reports · 64 citations
https://doi.org/10.1038/s41598-021-98253-9
K
Kazuya Sakai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
146
Papers
1.4K
Citations
20
h-index
33
i10-index
Kazuya Sakai is an academic researcher from Nara Medical University. The author has contributed to research in topics: Complement system in diseases & Platelet Disorders and Treatments & Coagulation, Bradykinin, Polyphosphates, and Angioedema. The author has an h-index of 20, co-authored 125 publications.
ORCID: 0000-0003-0523-7931Papers by this author
worksDiagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023
2023 · International Journal of Hematology · 38 citations
https://doi.org/10.1007/s12185-023-03657-0
TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review
2016 · Modern Rheumatology · 36 citations
https://doi.org/10.3109/14397595.2015.1120389
Serum cholinesterase associated with COVID-19 pneumonia severity and mortality
2020 · Journal of Infection · 32 citations
https://doi.org/10.1016/j.jinf.2020.08.021
Success and limitations of plasma treatment in pregnant women with congenital thrombotic thrombocytopenic purpura
2020 · Journal of Thrombosis and Haemostasis · 30 citations
https://doi.org/10.1111/jth.15064
Open ADAMTS-13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpura
2023 · Journal of Thrombosis and Haemostasis · 10 citations
https://doi.org/10.1016/j.jtha.2023.10.014
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat